This website uses cookies
More information
The monthly news publication for aviation professionals.

ACE 2026 - The home of global charter.

Related information from the Handbook...

Blade Europe
Charter

Blade Urban Air Mobility

Joby Aviation
Aircraft

BAN's World Gazetteer

Monaco
New York
California
The bimonthly news publication for aviation professionals.

Request your printed copy

Joby completes acquisition of Blade passenger business
Blade’s passenger operations have been integrated into Joby, while its medical arm continues to operate independently as Strata Critical Medical.
Joby expects Blade’s customers to be among the first to experience its eVTOL aircraft.

Joby Aviation has completed the acquisition of Blade Air Mobility’s passenger business. The deal gives Joby access to Blade’s established network of terminals and loyal flyers in New York and Southern Europe, supporting a quicker move into commercial service once certification of its all-electric vertical takeoff and landing aircraft is achieved.

Blade flew over 50,000 passengers in 2024 from a network of 12 terminals, including lounges at JFK, Newark, Manhattan’s East and West Sides, and Wall Street. Under the new arrangement, Blade’s passenger operations will continue as a wholly-owned subsidiary of Joby, led by founder and CEO Rob Wiesenthal.

By leveraging Blade’s existing infrastructure and gradually transitioning its clientele from traditional helicopters to Joby’s eVTOL aircraft, Joby expects to accelerate commercial launch, reduce infrastructure costs and lower customer acquisition expenses. The deal also supports Joby’s upcoming launch in Dubai and lays groundwork for global expansion.

Simultaneously Blade’s medical division was not part of the sale and has been re-branded Strata Critical Medical (Strata), remaining a public company focused on mission-critical logistics and medical air services across the USA. Trinity Medical Solutions, one of the nation’s largest organ-transport operators, remains its wholly owned subsidiary.

Strata will benefit from a long-term eVTOL partnership with Joby, gaining access to Joby aircraft for medical operations. Joby becomes the preferred VTOL partner to Strata’s organ transport business in markets where Joby operates. The quiet, potentially lower-cost nature of Joby’s aircraft is expected to offer competitive advantages for Strata’s healthcare clients.

Financially, Blade is receiving up to USD 125 million, payable in Joby stock or cash, including up to USD 35 million in performance-based holdbacks. The divestiture is projected to be neutral on adjusted EBITDA and free cash flow, supported by about USD 7 million in annual corporate cost efficiencies.

At closing, Rob Wiesenthal will lead Blade as CEO and will chair Strata’s board. Will Heyburn and Melissa Tomkiel will serve as co-CEOs of Strata, retaining their respective roles as CFO and General Counsel. Eric Affeldt becomes lead independent director.

Other News
 
Joby's installation in Dayton, Ohio is timely
January 12, 2026
In July 2025, Joby announced the completion of an expanded manufacturing facility in Marina, California and in October, confirmed the start of propeller blade production in Ohio. It intends to double production.
Joby boosts training options through CAE collaboration
January 10, 2026
Along with high-fidelity visuals, the simulator includes audio cues, turbulence and vibration systems that closely mirror real-world flight conditions, including the unique condition of wind flow around ground-based structures.
Joby concludes flight testing year with demo in Japan
December 18, 2025
The Fuji Speedway campaign capped a year of accelerated global operations that generated certification data and supported readiness for FAA type inspection authorisation in 2026.